Brian Piekos
Equibles does not estimate personal net worth.
Get an email with a short summary when Elicio Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ELTX alertsAbout Brian Piekos
Brian Piekos is recorded as CFO at Elicio Therapeutics, Inc. (ELTX) since June 1, 2023. Elicio Therapeutics, Inc. reported in an 8-K filed August 30, 2024 that Brian Piekos resigned as Chief Financial Officer and Treasurer, effective September 6, 2024. Elicio Therapeutics, Inc. reported in an 8-K filed June 2, 2023 that Brian Piekos was appointed Chief Financial Officer, effective June 1, 2023. The proxy statement of Elicio Therapeutics, Inc. reports total compensation of $878,755 for Brian Piekos in fiscal 2023, including a base salary of $273,548. Elicio Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Elicio Therapeutics, Inc. includes Robert Connelly (CEO, Chief Accounting Officer and Board Member), Julian Adams (Chairman), Julian Adams, Ph.D. (Chairman and Board Member) and 7 others.
“On August 27, 2024, Brian Piekos, the Chief Financial Officer and Treasurer of Elicio Therapeutics, Inc. (the "Company"), informed the Company of his intent to resign from his positions, effective September 6, 2024, to pursue another opportunity.”
“At the effective time of the Merger, the Company's board of directors (and its committees) and executive officers were reconstituted to include the following directors and executive officers”
Affiliation history
-
Current
2023-06-01–present
-
2023-06-01–2024-09-06
-
Start not stated–2024-09-06
Company network
Leadership on record at Elicio Therapeutics, Inc.
- Robert Connelly CEO, Chief Accounting Officer, Board Member
- Julian Adams Chairman
- Julian Adams, Ph.D. Chairman, Board Member
- Preetam Shah, Ph.D., M.B.A. CFO, Chief Accounting Officer
- Jennifer J. Rhodes General Counsel
- Allen R. Nissenson Board Member
- Allen R. Nissenson, M.D. Board Member
- Assaf Segal Board Member
- Carol Ashe Board Member
- Jay R. Venkatesan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Elicio Therapeutics, Inc. (ELTX) | former Chief Financial Officer and Treasurer | $273,548 | $878,755 |